Sales rise 0.34% to Rs 2.93 crore
Net Loss of Parenteral Drugs (India) reported to Rs 32.04 crore in the quarter ended June 2021 as against net loss of Rs 32.22 crore during the previous quarter ended June 2020. Sales rose 0.34% to Rs 2.93 crore in the quarter ended June 2021 as against Rs 2.92 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales2.932.92 0 OPM %-89.76-199.66 -PBDT-36.72-35.67 -3 PBT-41.05-40.00 -3 NP-32.04-32.22 1Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
